脱细胞基质-透明质酸-藻酸盐杂化水凝胶构建多层全层口腔黏膜芯片
本研究用猪口腔黏膜脱细胞基质(dECM)与透明质酸/藻酸盐制成杂化水凝胶,在PDMS微流控芯片中三培养口腔角质形成细胞、牙龈成纤维细胞和内皮细胞,发现其支持黏膜分层与表型维持优于Matrigel/BME,可用于药物细胞毒性筛查和黏膜疾病建模。
要点
- 1% SDS脱细胞可较好保留口腔黏膜ECM成分。
- dECM-HA/Alg杂化水凝胶支持上皮分层及基质/内皮表型。
- 该水凝胶基口腔黏膜芯片可替代Matrigel用于临床前研究。
核心结论
- 1% SDS脱细胞方案有效保留口腔黏膜ECM,可制备可注射dECM水凝胶。
- 优化的dECM-HA/Alg杂化水凝胶在支持口腔微组织分层和表型维持方面优于Matrigel,是口腔黏膜芯片的优良替代基质。
研究设计与样本
- 实验研究:猪口腔黏膜经0.1-1% SDS脱细胞后制备5、10、20 mg/mL dECM水凝胶。
- 在PDMS微流控芯片中三培养NOK、HGF和HUVEC构建口腔黏膜芯片模型。
主要发现
- 1% SDS脱细胞保留更多ECM成分。
- dECM水凝胶增强NOK、HGF和HUVEC活力/增殖,优于Matrigel/BME。
- 水凝胶组口腔黏膜相关标志物(K14、Ki67、p63、Involucrin、E-cadherin、Von Willebrand factor)表达增加。
- HA/Alg与10 mg/mL dECM杂化水凝胶较Matrigel更好支持NOK分层并维持HGF和HUVEC天然表型。
- 该杂化水凝胶在芯片中形成具有分层上皮、基质腔和内皮网络的多层微组织构造,较其他基质和商业微流控装置更好复制天然口腔黏膜结构。
临床怎么用
- 该临床前口腔黏膜芯片可用于口腔药物细胞毒性筛查。
- 该模型有潜力用于口腔黏膜疾病的建模研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Oral mucosa-on-a-chip (OMoC) devices mimic oral epithelium but require continuous nutrient support from underlying lamina propria. However, the common Matrigel or Basement membrane extract (BME) may not effectively support the oral mucosa (OM) native architecture. This study investigated whether a hybrid hydrogel composed of OM decellularized extracellular matrix (OM dECM), hyaluronic acid (HA), and alginate (Alg) surpasses Matrigel and BME for OMoC applications. METHODS: Porcine OM tissues were decellularized using 0.1-1 % sodium dodecyl sulfate (SDS), then freeze-dried, and pepsin-digested to produce OM dECM hydrogels (5, 10, and 20 mg/mL). DNA quantification, histological, biochemical and rheological assays, electron microscopy, and mass spectrometry were performed for dECM/hydrogels. Normal oral keratinocytes (NOK), gingival fibroblasts (HGF), and human umbilical vein endothelial cells (HUVEC) cultured in hydrogels were evaluated with proliferation, cytotoxicity, and immunocytochemistry (ICC) assays, and compared to Matrigel/BME. Hybrid hydrogels were used to tri-culture NOK, HGF, and HUVEC in a polydimethylsiloxane (PDMS)-based microfluidic chip for OM modeling. RESULTS: The 1 % SDS decellularization preserved greater ECM components. OM dECM hydrogels enhanced NOK, HGF, and HUVEC viability/proliferation, outperforming Matrigel/BME. Expression of OM-related markers (K14, Ki67, p63, Involucrin, E-cadherin, Von Willebrand factor) increased with hydrogels. Hybrid hydrogel of HA/Alg and 10 mg/mL dECM better supported NOK stratification while maintaining the native phenotype of HGF and HUVEC compared to Matrigel. Within our PDMS-based OMoC, the hybrid hydrogel facilitated the formation of a multi-layered microtissue construct with a stratified epithelial layer, a stromal compartment, and an endothelial network, better replicating the structural features of native OM as compared to other matrices and commercial microfluidic devices. CONCLUSIONS: A 1 % SDS decellularization protocol effectively preserved OM ECM, enabling development of an injectable OM dECM hydrogel. The optimized dECM-HA/Alg hybrid hydrogel outperformed Matrigel in supporting oral microtissue stratification, and phenotype maintenance, making it a superior alternative for OMoC applications. CLINICAL SIGNIFICANCE: This study developed a pre-clinical hybrid hydrogel-based OMoC that can more accurately replicate the oral mucosa ECM and tissue architecture when compared to Matrigel/BME. By enhancing the ECM mimicry, the dECM-HA/Alg hybrid hydrogel supported the development of an optimized OMoC for cytotoxicity screening of oral drugs and potential disease modeling of oral mucosal conditions.
引用
- Phan TV, Pimpakan T, Suwanchaikasem P, et al. Decellularized matrix-hyaluronic acid-alginate hybrid hydrogels to enable a multi-layered full-thickness oral mucosa-on-a-chip. J Dent. 2025. PMID: 40976276. doi:10.1016/j.jdent.2025.106115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。